Infliximab biosimilar CT-P13 for inflammatory bowel disease
2018-01-01 Bonovas, S; Peyrin-Biroulet, L; Danese, S
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
2018-01-01 Momozawa, Y; Dmitrieva, J; Theatre, E; Deffontaine, V; Rahmouni, S; Charloteaux, B; Crins, F; Docampo, E; Elansary, M; Gori, As; Lecut, C; Mariman, R; Mni, M; Oury, C; Altukhov, I; Alexeev, D; Aulchenko, Y; Amininejad, L; Bouma, G; Hoentjen, F; Lowenberg, M; Oldenburg, B; Pierik, Mj; vander Meulen-de Jong, Ae; van der Woude, Cj; Visschedijk, Mc; Lathrop, M; Hugot, Jp; Weersma, Rk; De Vos, M; Franchimont, D; Vermeire, S; Kubo, M; Louis, E; Georges, M; Abraham, C; Achkar, Jp; Ahmad, T; Ananthakrishnan, An; Andersen, V; Anderson, Ca; Andrews, Jm; Annese, V; Aumais, G; Baidoo, L; Baldassano, Rn; Bampton, Pa; Barclay, M; Barrett, Jc; Bayless, Tm; Bethge, J; Bitton, A; Boucher, G; Brand, S; Brandt, B; Brant, Sr; Buning, C; Chew, A; Cho, Jh; Cleynen, I; Cohain, A; Croft, A; Daly, Mj; D'Amato, M; Danese, S; De Jong, D; Denapiene, G; Denson, La; Devaney, Kl; Dewit, O; D'Inca, R; Dubinsky, M; Duerr, Rh; Edwards, C; Ellinghaus, D; Essers, J; Ferguson, Lr; Festen, Ea; Fleshner, P; Florin, T; Franke, A; Fransen, K; Gearry, R; Gieger, C; Glas, J; Goyette, P; Green, T; Griffiths, Am; Guthery, Sl; Hakonarson, H; Halfvarson, J; Hanigan, K; Haritunians, T; Hart, A; Hawkey, C; Hayward, Nk; Hedl, M; Henderson, P; Hu, Xh; Huang, Hl; Hui, Ky; Imielinski, M; Ippoliti, A; Jonaitis, L; Jostins, L; Karlsen, Th; Kennedy, Na; Khan, Ma; Kiudelis, G; Krishnaprasad, K; Kugathasan, S; Kupcinskas, L; Latiano, A; Laukens, D; Lawrance, Ic; Lee, Jc; Lees, Cw; Leja, M; Van Limbergen, J; Lionetti, P; Liu, Jz; Mahy, G; Mansfield, J; Massey, D; Mathew, Cg; Mcgovern, Dpb; Milgrom, R; Mitrovic, M; Montgomery, Gw; Mowat, C; Newman, W; Ng, A; Ng, Sc; Ng, Sme; Nikolaus, S; Ning, K; Nothen, M; Oikonomou, I; Palmieri, O; Parkes, M; Phillips, A; Ponsioen, Cy; Potocnik, U; Prescott, Nj; Proctor, Dd; Radford-Smith, G; Rahier, Jf; Raychaudhuri, S; Regueiro, M; Rieder, F; Rioux, Jd; Ripke, S; Roberts, R; Russell, Rk; Sanderson, Jd; Sans, M; Satsangi, J; Schadt, Ee; Schreiber, S; Schulte, D; Schumm, Lp; Scott, R; Seielstad, M; Sharma, Y; Silverberg, Ms; Simms, La; Skieceviciene, J; Spain, Sl; Steinhart, Ah; Stempak, Jm; Stronati, L; Sventoraityte, J; Targan, Sr; Taylor, Km; ter Velde, A; Torkvist, L; Tremelling, M; van Sommeren, S; Vasiliauskas, E; Verspaget, Hw; Walters, T; Wang, K; Wang, Mh; Wei, Z; Whiteman, D; Wijmenga, C; Wilson, Dc; Winkelmann, J; Xavier, Rj; Zhang, B; Zhang, Ck; Zhang, H; Zhang, W; Zhao, Hy; Zhao, Zz
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration
2018-01-01 Danese, S; Furfaro, F; Vetrano, S
Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis
2018-01-01 Danese, S; D'Amico, F; Bonovas, S; Peyrin-Biroulet, L
Unmet Needs in IBD: the Case of Fatigue
2018-01-01 Hindryckx, P; Laukens, D; D'Amico, F; Danese, S
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis
2019-01-01 Hanauer, S; Panaccione, R; Danese, S; Cheifetz, A; Reinisch, W; Higgins, Pdr; Woodworth, Da; Zhang, Hy; Friedman, Gs; Lawendy, N; Quirk, D; Nduaka, Ci; Su, Cy
Biosimilar and Originator Product in Inflammatory Bowel Diseases: Mind the Gap?
2019-01-01 Kotze, Pg; Danese, S
Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?
2019-01-01 D'Amico, F; Roda, G; Peyrin-Biroulet, L; Danese, S
Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease: Research Drives Clinic
2019-01-01 Argollo, M; Danese, S
Are Surgical Rates Decreasing in the Biological Era In IBD?
2019-01-01 Di Candido, F; Fiorino, G; Spadaccini, M; Danese, S; Spinelli, A
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies
2019-01-01 Beeg, M; Nobili, A; Orsini, B; Rogai, F; Gilardi, D; Fiorino, G; Danese, S; Salmona, M; Garattini, S; Gobbi, M
Medico-surgical Management: A Solid Therapeutic Pillar for Improved Patients' Outcomes in Inflammatory Bowel Diseases
2019-01-01 Kotze, Pg; Peyrin-Biroulet, L; Danese, S
Serum bile acids profiling in IBD patients treated with anti-TNFs
2019-01-01 Roda, G; Porru, E; Katsanos, K; Skamnelos, A; Kyriakidi, K; Christodoulou, Dk; Caliceti, C; Fiorino, G; Danese, S; Roda, A
Big data in IBD: a look into the future
2019-01-01 Olivera, P; Danese, S; Jay, N; Natoli, G; Peyrin-Biroulet, L
Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease
2019-01-01 Lovisa, S; Genovese, G; Danese, S
COMPARISON BETWEEN PCA3 AND PHI SPECIFICTY AND SENSITIVITY IN PREDICTING THE PRESENCE OF CANCER AT INITIAL OR REPEAT BIOPSY
2013-01-01 Scattoni, V; Lazzeri, M; Lughezzani, G; De Luca, S; Passera, R; Bollito, E; Randone, D; Abdollah, F; Capitanio, U; Larcher, A; Lista, G; Gadda, Gm; Bini, V; Briganti, A; Guazzoni, G; Montorsi, F
Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre
2013-01-01 Briganti, A; Bianchi, M; Sun, M; Suardi, N; Gallina, A; Abdollah, F; Bertini, R; Colombo, R; Di Girolamo, V; Salonia, A; Scattoni, V; Karakiewicz, Pi; Guazzoni, G; Rigatti, P; Montorsi, F
A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy
2014-01-01 Ficarra, V; Minervini, A; Antonelli, A; Bhayani, S; Guazzoni, G; Longo, N; Martorana, G; Morgia, G; Mottrie, A; Porter, J; Simeone, C; Vittori, G; Zattoni, F; Carini, M
Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression
2014-01-01 Abrate, A; Buono, R; Canu, T; Esposito, A; Del Maschio, A; Luciano, R; Bettiga, A; Colciago, G; Guazzoni, G; Benigni, F; Hedlund, P; Altaner, C; Montorsi, F; Cavarretta, Itr
CONTEMPORARY MANAGEMENT OF PROSTATE CANCER PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: A POPULATION-BASED STUDY.
2015-01-01 Fossati, N; Lee, Jk; Trinh, Qd; Sammon, J; Sood, A; Larcher, A; Gandaglia, G; Guazzoni, G; Karakiewicz, Pi; Shariat, Sf; Montorsi, F; Briganti, A; Menon, M; Abdollah, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Infliximab biosimilar CT-P13 for inflammatory bowel disease | 1-gen-2018 | Bonovas, S; Peyrin-Biroulet, L; Danese, S | |
| IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes | 1-gen-2018 | Momozawa, Y; Dmitrieva, J; Theatre, E; Deffontaine, V; Rahmouni, S; Charloteaux, B; Crins, F; Docampo, E; Elansary, M; Gori, As; Lecut, C; Mariman, R; Mni, M; Oury, C; Altukhov, I; Alexeev, D; Aulchenko, Y; Amininejad, L; Bouma, G; Hoentjen, F; Lowenberg, M; Oldenburg, B; Pierik, Mj; vander Meulen-de Jong, Ae; van der Woude, Cj; Visschedijk, Mc; Lathrop, M; Hugot, Jp; Weersma, Rk; De Vos, M; Franchimont, D; Vermeire, S; Kubo, M; Louis, E; Georges, M; Abraham, C; Achkar, Jp; Ahmad, T; Ananthakrishnan, An; Andersen, V; Anderson, Ca; Andrews, Jm; Annese, V; Aumais, G; Baidoo, L; Baldassano, Rn; Bampton, Pa; Barclay, M; Barrett, Jc; Bayless, Tm; Bethge, J; Bitton, A; Boucher, G; Brand, S; Brandt, B; Brant, Sr; Buning, C; Chew, A; Cho, Jh; Cleynen, I; Cohain, A; Croft, A; Daly, Mj; D'Amato, M; Danese, S; De Jong, D; Denapiene, G; Denson, La; Devaney, Kl; Dewit, O; D'Inca, R; Dubinsky, M; Duerr, Rh; Edwards, C; Ellinghaus, D; Essers, J; Ferguson, Lr; Festen, Ea; Fleshner, P; Florin, T; Franke, A; Fransen, K; Gearry, R; Gieger, C; Glas, J; Goyette, P; Green, T; Griffiths, Am; Guthery, Sl; Hakonarson, H; Halfvarson, J; Hanigan, K; Haritunians, T; Hart, A; Hawkey, C; Hayward, Nk; Hedl, M; Henderson, P; Hu, Xh; Huang, Hl; Hui, Ky; Imielinski, M; Ippoliti, A; Jonaitis, L; Jostins, L; Karlsen, Th; Kennedy, Na; Khan, Ma; Kiudelis, G; Krishnaprasad, K; Kugathasan, S; Kupcinskas, L; Latiano, A; Laukens, D; Lawrance, Ic; Lee, Jc; Lees, Cw; Leja, M; Van Limbergen, J; Lionetti, P; Liu, Jz; Mahy, G; Mansfield, J; Massey, D; Mathew, Cg; Mcgovern, Dpb; Milgrom, R; Mitrovic, M; Montgomery, Gw; Mowat, C; Newman, W; Ng, A; Ng, Sc; Ng, Sme; Nikolaus, S; Ning, K; Nothen, M; Oikonomou, I; Palmieri, O; Parkes, M; Phillips, A; Ponsioen, Cy; Potocnik, U; Prescott, Nj; Proctor, Dd; Radford-Smith, G; Rahier, Jf; Raychaudhuri, S; Regueiro, M; Rieder, F; Rioux, Jd; Ripke, S; Roberts, R; Russell, Rk; Sanderson, Jd; Sans, M; Satsangi, J; Schadt, Ee; Schreiber, S; Schulte, D; Schumm, Lp; Scott, R; Seielstad, M; Sharma, Y; Silverberg, Ms; Simms, La; Skieceviciene, J; Spain, Sl; Steinhart, Ah; Stempak, Jm; Stronati, L; Sventoraityte, J; Targan, Sr; Taylor, Km; ter Velde, A; Torkvist, L; Tremelling, M; van Sommeren, S; Vasiliauskas, E; Verspaget, Hw; Walters, T; Wang, K; Wang, Mh; Wei, Z; Whiteman, D; Wijmenga, C; Wilson, Dc; Winkelmann, J; Xavier, Rj; Zhang, B; Zhang, Ck; Zhang, H; Zhang, W; Zhao, Hy; Zhao, Zz | |
| Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration | 1-gen-2018 | Danese, S; Furfaro, F; Vetrano, S | |
| Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis | 1-gen-2018 | Danese, S; D'Amico, F; Bonovas, S; Peyrin-Biroulet, L | |
| Unmet Needs in IBD: the Case of Fatigue | 1-gen-2018 | Hindryckx, P; Laukens, D; D'Amico, F; Danese, S | |
| Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis | 1-gen-2019 | Hanauer, S; Panaccione, R; Danese, S; Cheifetz, A; Reinisch, W; Higgins, Pdr; Woodworth, Da; Zhang, Hy; Friedman, Gs; Lawendy, N; Quirk, D; Nduaka, Ci; Su, Cy | |
| Biosimilar and Originator Product in Inflammatory Bowel Diseases: Mind the Gap? | 1-gen-2019 | Kotze, Pg; Danese, S | |
| Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference? | 1-gen-2019 | D'Amico, F; Roda, G; Peyrin-Biroulet, L; Danese, S | |
| Novel Targets for Therapeutic Intervention in Inflammatory Bowel Disease: Research Drives Clinic | 1-gen-2019 | Argollo, M; Danese, S | |
| Are Surgical Rates Decreasing in the Biological Era In IBD? | 1-gen-2019 | Di Candido, F; Fiorino, G; Spadaccini, M; Danese, S; Spinelli, A | |
| A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies | 1-gen-2019 | Beeg, M; Nobili, A; Orsini, B; Rogai, F; Gilardi, D; Fiorino, G; Danese, S; Salmona, M; Garattini, S; Gobbi, M | |
| Medico-surgical Management: A Solid Therapeutic Pillar for Improved Patients' Outcomes in Inflammatory Bowel Diseases | 1-gen-2019 | Kotze, Pg; Peyrin-Biroulet, L; Danese, S | |
| Serum bile acids profiling in IBD patients treated with anti-TNFs | 1-gen-2019 | Roda, G; Porru, E; Katsanos, K; Skamnelos, A; Kyriakidi, K; Christodoulou, Dk; Caliceti, C; Fiorino, G; Danese, S; Roda, A | |
| Big data in IBD: a look into the future | 1-gen-2019 | Olivera, P; Danese, S; Jay, N; Natoli, G; Peyrin-Biroulet, L | |
| Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease | 1-gen-2019 | Lovisa, S; Genovese, G; Danese, S | |
| COMPARISON BETWEEN PCA3 AND PHI SPECIFICTY AND SENSITIVITY IN PREDICTING THE PRESENCE OF CANCER AT INITIAL OR REPEAT BIOPSY | 1-gen-2013 | Scattoni, V; Lazzeri, M; Lughezzani, G; De Luca, S; Passera, R; Bollito, E; Randone, D; Abdollah, F; Capitanio, U; Larcher, A; Lista, G; Gadda, Gm; Bini, V; Briganti, A; Guazzoni, G; Montorsi, F | |
| Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre | 1-gen-2013 | Briganti, A; Bianchi, M; Sun, M; Suardi, N; Gallina, A; Abdollah, F; Bertini, R; Colombo, R; Di Girolamo, V; Salonia, A; Scattoni, V; Karakiewicz, Pi; Guazzoni, G; Rigatti, P; Montorsi, F | |
| A multicentre matched-pair analysis comparing robot-assisted versus open partial nephrectomy | 1-gen-2014 | Ficarra, V; Minervini, A; Antonelli, A; Bhayani, S; Guazzoni, G; Longo, N; Martorana, G; Morgia, G; Mottrie, A; Porter, J; Simeone, C; Vittori, G; Zattoni, F; Carini, M | |
| Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression | 1-gen-2014 | Abrate, A; Buono, R; Canu, T; Esposito, A; Del Maschio, A; Luciano, R; Bettiga, A; Colciago, G; Guazzoni, G; Benigni, F; Hedlund, P; Altaner, C; Montorsi, F; Cavarretta, Itr | |
| CONTEMPORARY MANAGEMENT OF PROSTATE CANCER PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: A POPULATION-BASED STUDY. | 1-gen-2015 | Fossati, N; Lee, Jk; Trinh, Qd; Sammon, J; Sood, A; Larcher, A; Gandaglia, G; Guazzoni, G; Karakiewicz, Pi; Shariat, Sf; Montorsi, F; Briganti, A; Menon, M; Abdollah, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27856
Data di pubblicazione
- In corso di stampa15
- 2020 - 20269594
- 2010 - 201911833
- 2000 - 20094578
- 1990 - 19991484
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS231
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE214
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19889
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25603
- reserved1362
- open891